MedPath
Found 1 clinical trials|View Analysis
Sort by:

Fruquintinib Sequential BEV+FOLFIRI vs. BEV+FOLFIRI Sequential Fruquintinib in Metastatic Colorectal Cancer

Phase 2
Not yet recruiting
Conditions
Metastatic Colorectal Cancer
Interventions
First Posted Date
2022-07-07
Last Posted Date
2022-07-07
Lead Sponsor
Weijian Guo
Target Recruit Count
134
Registration Number
NCT05447715
Locations
🇨🇳

Fudan University Cancer Hospital, ShangHai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath